Related Experiment Videos
Guillain-Barré syndrome
S Anne Joseph1, Chang-Yong Tsao
1The Ohio State University Columbus Children's Hospital, Columbus, Ohio 43205, USA.
Adolescent Medicine (Philadelphia, Pa.)
|September 25, 2002
Summary
Guillain-Barré syndrome is a common paralytic illness in children, triggered by autoimmune responses to infections or immunizations. This review covers its epidemiology, diagnosis, treatment, and outcomes.
Area of Science:
- Neurology
- Immunology
- Pediatrics
Background:
- Guillain-Barré syndrome is the leading cause of acute paralysis in children and adolescents in developed nations.
- It involves an autoimmune response to antecedent infections or immunizations, leading to acute polyradiculoneuropathy.
- Characterized by flaccid weakness, areflexia, and elevated cerebrospinal fluid protein.
Purpose of the Study:
- To provide a comprehensive review of Guillain-Barré syndrome in pediatric populations.
- To cover key aspects including epidemiology, clinical presentation, and diagnostic criteria.
- To discuss pathogenesis, treatment strategies, and patient outcomes.
Main Methods:
- Literature review of Guillain-Barré syndrome epidemiology.
- Analysis of clinical presentation and diagnostic criteria.
- Synthesis of information on pathogenesis, treatment, and outcomes.
Main Results:
- Guillain-Barré syndrome presents as acute, symmetrical flaccid paralysis with areflexia.
- Diagnosis relies on clinical findings and cerebrospinal fluid analysis.
- Treatment options and prognostic factors are detailed.
Conclusions:
- Guillain-Barré syndrome requires prompt diagnosis and management.
- Understanding its pathogenesis aids in developing targeted therapies.
- Multidisciplinary care is crucial for optimal outcomes in affected children.